Rosa & Co. announced the renewal of a multi-year Research Agreement with Sanofi to provide Rosa’s PhysioPD services.
The agreement extends Sanofi’s access to Rosa’s PhysioPD research teams. It increases continuity of research teams and enables deeper access to Rosa’s extensive PhysioPD-related intellectual property.
The renewal of the Sanofi PhysioPD Research Agreement extends Rosa’s global leadership in QSP, a well-documented approach to help pharma and biopharma optimize the evaluation of novel targets and compounds, guide trial designs, and inform competitive differentiation.